We are live on ! Find out more
AAMU

Amundi Asset Management US Portfolio holdings

AUM $131B
1-Year Est. Return 73.57%
This Fund
S&P 500
This Quarter Est. Return
+7.44%
1 Year Est. Return
+73.57%
3 Year Est. Return
+113.87%
5 Year Est. Return
+203.49%
10 Year Est. Return
AUM
$76.3B
AUM Growth
+$6.95B
Cap. Flow
+$3.2B
Cap. Flow %
4.2%
Top 10 Hldgs %
17.17%
Holding
1,688
New
122
Increased
747
Reduced
515
Closed
80

Sector Composition

Rank Sector Weight
1 Technology 18.28%
2 Financials 14.68%
3 Healthcare 14.21%
4 Consumer Discretionary 11.56%
5 Industrials 11.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TERP
1401
DELISTED
TerraForm Power, Inc
TERP
$154K ﹤0.01%
13,300
DSGX icon
1402
Descartes Systems
DSGX
$6.82B
$153K ﹤0.01%
+4,500
New +$152K
FICO icon
1403
Fair Isaac
FICO
$22.5B
$153K ﹤0.01%
670
CW icon
1404
Curtiss-Wright
CW
$25.5B
$150K ﹤0.01%
1,088
CDTX
1405
DELISTED
Cidara Therapeutics
CDTX
$148K ﹤0.01%
1,680
IFRX icon
1406
InflaRx
IFRX
$271M
$148K ﹤0.01%
4,300
XENE icon
1407
Xenon Pharmaceuticals
XENE
$6.12B
$148K ﹤0.01%
+11,200
New +$130K
CRSP icon
1408
CRISPR Therapeutics
CRSP
$5.17B
$142K ﹤0.01%
3,200
CLGX
1409
DELISTED
Corelogic, Inc.
CLGX
$142K ﹤0.01%
2,875
MKSI icon
1410
MKS Inc
MKSI
$20.6B
$140K ﹤0.01%
1,745
-281,726
-99% -$25.7M
SHSP
1411
DELISTED
SharpSpring, Inc.
SHSP
$139K ﹤0.01%
+9,900
New +$120K
MOH icon
1412
Molina Healthcare
MOH
$10.3B
$137K ﹤0.01%
+922
New +$118K
CTLT
1413
DELISTED
CATALENT, INC.
CTLT
$135K ﹤0.01%
2,968
-7,251
-71% -$306K
BSTC
1414
DELISTED
BioSpecifics Technologies Corp.
BSTC
$135K ﹤0.01%
+2,300
New +$117K
TBPH icon
1415
Theravance Biopharma
TBPH
$877M
$134K ﹤0.01%
+4,100
New +$112K
VCYT icon
1416
Veracyte
VCYT
$3.8B
$134K ﹤0.01%
+14,000
New +$154K
WIFI
1417
DELISTED
Boingo Wireless, Inc.
WIFI
$133K ﹤0.01%
3,800
LAKE icon
1418
Lakeland Industries
LAKE
$119M
$132K ﹤0.01%
9,900
NJR icon
1419
New Jersey Resources
NJR
$5.58B
$132K ﹤0.01%
+2,861
New +$132K
ESV
1420
DELISTED
Ensco Rowan plc
ESV
$131K ﹤0.01%
3,875
+250
+7% +$7.15K
JD icon
1421
JD.com
JD
$44.5B
$130K ﹤0.01%
+5,000
New +$164K
MMS icon
1422
Maximus
MMS
$3.1B
$128K ﹤0.01%
1,974
-2,173
-52% -$141K
NYRT
1423
DELISTED
New York REIT, Inc.
NYRT
$128K ﹤0.01%
7,049
INO icon
1424
Inovio Pharmaceuticals
INO
$69M
$126K ﹤0.01%
1,883
+966
+105% +$53.8K
KNSA icon
1425
Kiniksa Pharmaceuticals
KNSA
$5.93B
$125K ﹤0.01%
+4,900
New +$95.3K

Similar funds

Amundi Asset Management US's Q3 2018 Portfolio in Review

As of Q3 2018, Amundi Asset Management US held 1,688 positions worth $76.3B, up 10% from $69.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Amundi Asset Management US deployed $3.2B of net new capital in Q3 2018, opening 122 new positions and adding to 747 existing holdings. Its largest new stake was Evoqua Water Technologies Corp. Common Stock: 1,208,837 shares worth $21.5M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $204M trimmed.

  • Amundi Asset Management US's largest Q3 2018 buy was Evoqua Water Technologies Corp. Common Stock: 1,208,837 shares worth $21.5M.
  • Amundi Asset Management US added most to Meta Platforms (Facebook) in Q3 2018, an estimated $233M increase.
  • Amundi Asset Management US's biggest Q3 2018 reduction was Microsoft, cutting an estimated $204M.
  • Amundi Asset Management US fully exited MasTec in Q3 2018, selling an estimated $18.8M.
  • Amundi Asset Management US's ten largest holdings make up 17% of its $76.3B portfolio in Q3 2018.
  • Amundi Asset Management US opened 122 new positions and closed 80 in Q3 2018.
  • Amundi Asset Management US's portfolio value rose 10% quarter-over-quarter to $76.3B.

Based on Amundi Asset Management US's 13F filing for Q3 2018, filed 14 Nov 2018.